Independent risk factors for mortality in VL/HIV co-infection.

* at time of VL diagnosis;
aCompared to those never started on ART.
1Tuberculosis not retained, but borderline significant (adjusted HR: 2.5 (95% CI 1.0–6.2); P 0.053 in stepwise model).
Sensitivity analysis 1: alternative strategy to account for missing data.
Sensitivity analysis 2: continuous co-variates entered in original form (no categorization).
VL – Visceral Leishmaniasis; HIV – Human Immunodeficiency Virus; BMI – Body Mass Index; HR – Hazard Ratio; CI – Confidence Interval; ART –Antiretroviral Therapy.